纖維蛋白原α(FGA)重組蛋白
Recombinant Fibrinogen Alpha Chain (FGA)
Fib2; FG-A; FGA; Fibrinopeptide A
- 編號RPB154Mu01
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌
- 預測分子量25.5kDa
- 實際分子量29kDa(差異分析請參閱說明書)
- 片段與標簽Trp357~Asp556 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 95%
- 等電點6.5
-
應用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 960 ¥ 2400 ¥ 4800 ¥ 14400 ¥ 36000
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure. Gene Sequencing (Extract)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
增值服務
相關產(chǎn)品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPB154Mu02 | 纖維蛋白原α(FGA)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB154Mu01 | 纖維蛋白原α(FGA)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB154Mu01 | 纖維蛋白原α(FGA)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB154Mu02 | 纖維蛋白原α(FGA)多克隆抗體 | WB; IHC; ICC; IP. |
| LAB154Mu71 | 纖維蛋白原α(FGA)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| MEB154Mu | 纖維蛋白原α(FGA)檢測試劑盒(酶聯(lián)免疫吸附試驗法,小樣本) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SEB154Mu | 纖維蛋白原α(FGA)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB154Mu | 纖維蛋白原α(FGA)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| KSB154Mu01 | 纖維蛋白原α(FGA)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| PLoS One | Plasma Protein Biomarkers of Hepatocellular Carcinoma in HCV-Infected Alcoholic Patients with Cirrhosis [PubMed: 25789864] |
| United States Patent Application | Compositions and Methods for Diagnosing Lung Cancer [y2016:0077095.html] |
| GLYCOCONJUGATE JOURNAL | Nattokinase-heparin exhibits beneficial efficacy and safety—an optimal strategy for CKD patients on hemodialysis [Pubmed: 30788657] |
| Proteomics Clinical Applications | Comparative proteomics analysis of serum proteins in gestational diabetes during early and middle stages of pregnancy [Pubmed: 31162828] |
| Reproductive BioMedicine Online | Fibrinogen alpha chain is upregulated and affects the pathogenesis of endometriosis [] |
| Redox Biology | Breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting LPS-induced … [Pubmed: 32193146] |
留言咨詢
